PAK1 and neoplasm: Comparably, our RNA-seq and qRT-PCR results showed that pak1 was down-regulated in pax3a−/−;pax3b−/− double mutants, in particular in the slow progressing tumours, which makes pak1 a plausible driver of fusion negative RMS progression in our model.